Shandong Pharmaceutical Glass Co Ltd (600529) — Cash Flow Reinvestment Rate
Shandong Pharmaceutical Glass Co Ltd (600529) has a Cash Flow Reinvestment Rate of 5.03x as of December 2025, reinvesting CN¥208.74 Million (capex CN¥153.18 Million plus investments CN¥55.56 Million) from operating cash flow of CN¥41.46 Million. See free cash flow generation of Shandong Pharmaceutical Glass Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Pharmaceutical Glass Co Ltd Cash Flow Reinvestment Rate (2001–2025)
Historical reinvestment intensity for Shandong Pharmaceutical Glass Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see 600529 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year capital reinvestment analysis for Shandong Pharmaceutical Glass Co Ltd. See Shandong Pharmaceutical Glass Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥311.94 Million | CN¥576.92 Million | CN¥231.86 Million | ▼ -43.7% |
| 2024 | 0.96x | CN¥1.12 Billion | CN¥1.17 Billion | CN¥647.79 Million | ▼ -29.0% |
| 2023 | 1.35x | CN¥1.42 Billion | CN¥1.05 Billion | CN¥671.53 Million | ▼ -77.4% |
| 2022 | 5.97x | CN¥1.51 Billion | CN¥252.44 Million | CN¥710.71 Million | ▲ +407.1% |
| 2021 | 1.18x | CN¥883.26 Million | CN¥750.44 Million | CN¥809.26 Million | ▼ -12.9% |
| 2020 | 1.35x | CN¥765.20 Million | CN¥566.01 Million | CN¥535.20 Million | ▼ -11.9% |
| 2019 | 1.54x | CN¥919.69 Million | CN¥599.05 Million | CN¥591.69 Million | ▼ -1.7% |
| 2018 | 1.56x | CN¥727.38 Million | CN¥465.77 Million | CN¥347.38 Million | ▲ +32.0% |
| 2017 | 1.18x | CN¥487.24 Million | CN¥411.96 Million | CN¥167.06 Million | ▲ +102.9% |
| 2016 | 0.58x | CN¥295.25 Million | CN¥506.53 Million | CN¥196.58 Million | ▲ +22.7% |
| 2015 | 0.48x | CN¥185.12 Million | CN¥389.63 Million | CN¥155.12 Million | ▼ -5.1% |
| 2014 | 0.50x | CN¥133.53 Million | CN¥266.63 Million | CN¥133.53 Million | ▼ -10.6% |
| 2013 | 0.56x | CN¥150.49 Million | CN¥268.60 Million | CN¥150.49 Million | ▼ -86.9% |
| 2012 | 4.28x | CN¥122.10 Million | CN¥28.52 Million | CN¥122.10 Million | ▲ +440.5% |
| 2011 | 0.79x | CN¥217.53 Million | CN¥274.63 Million | CN¥217.53 Million | ▼ -14.2% |
| 2010 | 0.92x | CN¥200.37 Million | CN¥217.01 Million | CN¥200.37 Million | ▲ +94.3% |
| 2009 | 0.48x | CN¥118.44 Million | CN¥249.27 Million | CN¥118.44 Million | ▼ -72.5% |
| 2008 | 1.73x | CN¥158.40 Million | CN¥91.76 Million | CN¥158.40 Million | ▲ +31.6% |
| 2007 | 1.31x | CN¥160.82 Million | CN¥122.63 Million | CN¥160.82 Million | ▲ +45.8% |
| 2006 | 0.90x | CN¥70.59 Million | CN¥78.47 Million | CN¥70.59 Million | ▼ -53.4% |
| 2005 | 1.93x | CN¥85.09 Million | CN¥44.09 Million | CN¥85.09 Million | ▼ -57.8% |
| 2003 | 4.58x | CN¥271.74 Million | CN¥59.35 Million | CN¥271.74 Million | ▲ +344.7% |
| 2002 | 1.03x | CN¥112.49 Million | CN¥109.26 Million | CN¥112.49 Million | ▲ +16.3% |
| 2001 | 0.89x | CN¥25.32 Million | CN¥28.60 Million | CN¥25.32 Million | — |